Rama Rao K
CEO & Founder
Rama is a senior executive with 27 years of extensive experience in the pharmaceutical industry with Eli Lilly and Novartis. He worked in a multiplicity of senior executive roles including being the Global Head for Development Finance for Novartis Oncology, the Head of Development Finance for the US and the CFO of Novartis Pharma in Canada/Russia.
Delivering innovative solutions to address inefficiencies in the Pharmaceutical value chain, for the benefit of patients, is my passion. My strategic skills, problem solving approach, inspiring teams, delivering innovative solutions to challenging issues and proactively identifying solutions to strategic roadblocks makes me unique. As CFO I have led complex operations in different business environments, in multiple countries ( US, Canada, Russia, Europe and Africa) with a P&L range upto $3B in challenging environments. I led with integrity, developed talent, delivered innovative solutions and partnered to deliver top tier performance. Functionally I have covered FP&A, Licensing, M&A, IT, Sourcing, Supply Chain, Operations, Treasury and Clinical Development Finance and the usage of LEAN methodologies to streamline processes. Bilingual ( French/English); schooled at ‘Ivy league schools’ of India (IIT/IIM)and France (INSEAD).
A pharma executive with more than 25 years of experience in the pharmaceutical and contract research organization industry in corporate executive management, international business development, drug discovery and development particularly in the areas of oncology, neurology, bone biology and pharmaceutical quality, and medical device development, particularly in the areas of synthetic organic and medicinal chemistry, analytical and bioanalytical chemistry, drug delivery, design and conduct of pre-clinical and clinical studies, GMP manufacturing and regulatory affairs.
Currently working in Scientific Affairs at Medisca Inc. Former Adjunct Professor of Oncology at McGill University. Formerly held the positions of Chairman & CEO of Osta Biotechnologies Inc., Chief Operating Officer and Executive Vice-President of Therapeutics Delivery at BioSyntech Inc.; Director of Chemistry at Neurochem Inc.; Manager, GMP Synthesis/Senior Research Chemist at MDS Inc. and Director, Analytical/ADME/Pharmacy at ITR Laboratories Inc. a Ph.D. in synthetic organic chemistry from the University of Waterloo, Ontario.
Specialties: Executive management, business development, strategic alliances and partnerships, raising capital, running a publicly traded company, Drug discovery & development, medicinal chemistry, rationale drug design, cGMP manufacturing , analytical and bioanalytical chemistry, medical device discovery and development, regulatory, QA, design of PK/TK studies and modelling, design of GLP preclinical toxicology and safety pharmacology studies, preparation of CMC section, drug delivery. Expert in OOS/OOT investigations, root cause analysis, CAPAs and continuous improvements, equipment qualifications, SOP writing, method validations, occupational exposure controls, cleaning validations, transport validation, container/closure system selection.
Mr. Gupta is a Leading lawyer in the Blockchain and Cryptocurrency Industry with 20 years of top-notch professional experience including founding Chief Legal Officer of Bitfury Group , Co-Founder Crypton Labs and Partner at major US and international law firms.
C-level legal and business executive with over 20 years of professional experience including founding Chief Legal Officer of a technology start-up valued at $1 billion and Partner at major US and international law firms.